Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
12th week of 2022 patent applcation highlights part 27
Patent application number
Title
Published
20220089698
ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE
2022-03-24
20220089699
COMBINATIONS OF ANTI-STAPHYLOCOCCUS AUREUS ANTIBODIES
2022-03-24
20220089700
ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS AND METHODS OF USING THE SAME
2022-03-24
20220089701
ANTI-GALACTOFURANOSE ANTIBODIES FOR DETECTING AND TREATING ASPERGILLOSIS
2022-03-24
20220089702
ANTIBODIES RECOGNIZING TAU
2022-03-24
20220089703
AGGRECAN BINDING IMMUNOGLOBULINS
2022-03-24
20220089704
HUMANIZED AND STABILIZED FC5 VARIANTS FOR ENHANCEMENT OF BLOOD BRAIN BARRIER TRANSPORT
2022-03-24
20220089705
ANTI-AP2 ANTIBODIES AND ANTIGEN BINDING AGENTS TO TREAT METABOLIC DISORDERS
2022-03-24
20220089706
ANTI-ELASTIN ANTIBODIES AND METHODS OF USE
2022-03-24
20220089707
MONOCLONAL ANTIBODIES AGAINST MHC-BOUND HUMAN DICKKOPF-1 PEPTIDES AND USES THEREOF
2022-03-24
20220089708
ANTIBODY COMPOSITIONS TARGETING NON-PHOSPHORYLATED ALPHA-SYNUCLEIN AGGREGATES
2022-03-24
20220089709
PROTEIN BINDING TO FIBRONECTIN B DOMAIN
2022-03-24
20220089710
Method of Treating Signs and Symptoms of Osteoarthritis
2022-03-24
20220089711
METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3
2022-03-24
20220089712
Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins
2022-03-24
20220089713
FORMULATIONS OF MONOCLONAL ANTIBODIES
2022-03-24
20220089714
Treatment Of Non-Alcoholic Steatohepatitis (NASH) With IL-27 Antibody
2022-03-24
20220089715
METHODS OF NEUTRALIZING IL-8 BIOLOGICAL ACTIVITY
2022-03-24
20220089716
TRANSITION ANALYSIS METHOD FOR CHROMATOGRAPHY COLUMN QUALIFICATION
2022-03-24
20220089717
MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
2022-03-24
20220089718
CHIMERIC ANTIGEN RECEPTORS WITH MODIFIED LINKER DOMAINS AND USES THEREOF
2022-03-24
20220089719
CONSTRUCTS TARGETING LABYRINTHIN OR A PORTION THEREOF AND USES THEREOF
2022-03-24
20220089720
ANTIBODIES AGAINST TIM3 AND USES THEREOF
2022-03-24
20220089721
PHARMACEUTICAL COMBINATION OF ANTI CEACAM6 AND TIM3 ANTIBODIES
2022-03-24
20220089722
HETERODIMERIC FUSION PROTEIN
2022-03-24
20220089723
LILRB3-BINDING MOLECULES AND USES THEREFOR
2022-03-24
20220089724
TREATMENT OF NEUROTOXICITY AND/OR CYTOKINE RELEASE SYNDROME
2022-03-24
20220089725
FCMR-Binding Molecules and Uses Thereof
2022-03-24
20220089726
TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS
2022-03-24
20220089727
Anti-CD47 monoclonal antibody and use thereof
2022-03-24
20220089728
ANTIGEN BINDING PROTEINS
2022-03-24
20220089729
MULTISPECIFIC HEAVY CHAIN ANTIBODIES WITH MODIFIED HEAVY CHAIN CONSTANT REGIONS
2022-03-24
20220089730
ANTIGEN BINDING CONSTRUCTS TO TARGET MOLECULES
2022-03-24
20220089731
METHODS AND COMPOSITIONS FOR MODULATING BETA CHAIN MEDIATED IMMUNITY
2022-03-24
20220089732
ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF
2022-03-24
20220089733
NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION
2022-03-24
20220089734
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
2022-03-24
20220089735
ANTI-B7S1 POLYPEPTIDES AND THEIR USE
2022-03-24
20220089736
IMMUNE TARGETING MOLECULES AND USES THEREOF
2022-03-24
20220089737
MULTI-SPECIFIC IMMUNE TARGETING MOLECULES AND USES THEREOF
2022-03-24
20220089738
Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof
2022-03-24
20220089739
Antibodies Directed Against Programmed Death-1 (PD-1)
2022-03-24
20220089740
TIM-3 ANTIBODIES AND COMBINATIONS WITH OTHER CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER
2022-03-24
20220089741
BINDER AGAINST PROGRAMMED DEATH-LIGAND AND APPLICATION THEREOF
2022-03-24
20220089742
COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING TUMOR
2022-03-24
20220089743
ANTI-HLA-DQ2.5 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE
2022-03-24
20220089744
ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
2022-03-24
20220089745
ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIES
2022-03-24
20220089746
GALECTIN-7-SPECIFIC MONOVALENT ANTIBODIES AND USES THEREOF
2022-03-24
20220089747
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLETING ANTIBODIES
2022-03-24
20220089748
PDGF RECEPTOR BETA BINDING POLYPEPTIDES
2022-03-24
20220089749
ANTI-EGFR COMBINATIONS FOR TREATING TUMORS
2022-03-24
20220089750
CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF
2022-03-24
20220089751
HUMANIZED ANTI-IL-1R3 ANTIBODIES
2022-03-24
20220089752
COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION
2022-03-24
20220089753
THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER
2022-03-24
20220089754
ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
2022-03-24
20220089755
ANTIBODY AGAINST THE ENDOTHELIN RECEPTOR SUBTYPE A, AND USES THEREOF
2022-03-24
20220089756
BISPECIFIC ANTIBODIES WITH CLEAVABLE C-TERMINAL CHARGE-PAIRED TAGS
2022-03-24
20220089757
ANTI-CD137L ANTIBODIES AND METHODS OF USING SAME
2022-03-24
20220089758
NOVEL ANTI-CD40 ANTIBODIES
2022-03-24
20220089759
USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF INFLAMMATORY CONDITIONS
2022-03-24
20220089760
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND METHODS OF USE
2022-03-24
20220089761
MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20
2022-03-24
20220089762
Anti-Abeta Antibodies
2022-03-24
20220089763
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
2022-03-24
20220089764
Antibody Molecules to C5AR1 and Uses Thereof
2022-03-24
20220089765
CD31 COMPETITORS AND USES THEREOF
2022-03-24
20220089766
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
2022-03-24
20220089767
CD47-CD38 BISPECIFIC ANTIBODIES
2022-03-24
20220089768
MULTI-SPECIFIC PROTEIN MOLECULES AND USES THEREOF
2022-03-24
20220089769
REMOVAL OF TARGET CELLS BY CIRCULATING VIRUS-SPECIFIC CYTOTOXIC T-CELLS USING MHC CLASS I COMPRISING COMPLEXES
2022-03-24
20220089770
NOVEL CANCER ANTIGENS AND ANTIBODIES OF SAID ANTIGENS
2022-03-24
20220089771
Targeting Intracellular Target-Binding Determinants with Intracellular Antibodies
2022-03-24
20220089772
ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES
2022-03-24
20220089773
HER2/neu-Specific Antibodies and Methods of Using Same
2022-03-24
20220089774
MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO CCSP-2 AND USE THEREOF
2022-03-24
20220089775
MULTIPLY AUXOTROPHIC CELL LINE FOR THE PRODUCTION OF RECOMBINANT PROTEINS AND METHODS THEREOF
2022-03-24
20220089776
THERAPEUTIC FACTOR XII ANTIBODY
2022-03-24
20220089777
NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF
2022-03-24
20220089778
COAGULATION FACTOR BINDING PROTEINS AND USES THEREOF
2022-03-24
20220089779
NME INHIBITORS AND METHODS OF USING NME INHIBITORS
2022-03-24
20220089780
KLOTHO BETA
2022-03-24
20220089781
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
2022-03-24
20220089782
NASAL SPRAY TO REDUCE COVID-19 TRANSMISSION
2022-03-24
20220089783
METHODS OF USING SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EBOLA VIRUS
2022-03-24
20220089784
Antibodies for Botulinum Neurotoxins
2022-03-24
20220089785
COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR GENE ASSEMBLY
2022-03-24
20220089786
TREATMENT OF SJOGREN'S DISEASE WITH NUCLEASE FUSION PROTEINS
2022-03-24
20220089787
METHOD FOR MANUFACTURING PROTEOGLYCAN-CONTAINING COMPOSITION, AND PROTEOGLYCAN-CONTAINING COMPOSITION
2022-03-24
20220089788
Rubber and By-Product Extraction Systems and Methods
2022-03-24
20220089789
METHOD FOR PRODUCING SUPERABSORBENT PARTICLES
2022-03-24
20220089790
Tetraarylborate Compound, Catalyst Composition Comprising Same, and Method for Preparing Ethylene Homopolymers or Copolymers of Ethylene and a-Olefin by Using Same
2022-03-24
20220089791
CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PRODUCING POLAR GROUP-CONTAINING OLEFIN POLYMER
2022-03-24
20220089792
ADDITIVE COMPOSITION
2022-03-24
20220089793
PRODUCTION METHOD FOR MODIFIED VINYL ALCOHOL POLYMER PARTICLE AND PARTICLE OBTAINED THEREBY
2022-03-24
20220089794
METHODS OF PREPARING A CATALYST
2022-03-24
20220089795
NOVEL NANOPARTICLES USING ANIONIC POLYMER, PREPARATION METHOD AND COMPOSITION THEREOF
2022-03-24
20220089796
HYDRATE KINETICS INHIBITOR
2022-03-24
20220089797
Olefin Polymer And Preparation Method Thereof
2022-03-24